The Need for “Compassionate Provider Profiling”
Author:
- Eric D. PetersonEPEric D. Peterson
Abstract
No abstract availableFunding Information
- American College of Cardiology
- Bristol-Myers Squibb Company
- Eli Lilly & Company
- Johnson & Johnson
- Merck & Co.
- Sanofi-Aventis
- Society of Thoracic Surgeons
- American Heart Association
This publication has 13 references indexed in Scilit:
- Improvement in Mortality Risk Prediction After Percutaneous Coronary Intervention Through the Addition of a “Compassionate Use” Variable to the National Cardiovascular Data Registry CathPCI DatasetJACC, 2011
- Accountability Measures — Using Measurement to Promote Quality ImprovementNew England Journal of Medicine, 2010
- Contemporary Mortality Risk Prediction for Percutaneous Coronary InterventionJACC, 2010
- Cottage Industry to Postindustrial Care — The Revolution in Health Care DeliveryNew England Journal of Medicine, 2010
- The Public Health Hazards of Risk Avoidance Associated With Public Reporting of Risk-Adjusted Outcomes in Coronary InterventionJACC, 2009
- Standards for Statistical Models Used for Public Reporting of Health OutcomesCirculation, 2006
- The Influence of Public Reporting of Outcome Data on Medical Decision Making by PhysiciansArchives of internal medicine (1960), 2005
- The American College of Cardiology-National Cardiovascular Data Registry™ (ACC-NCDR™): building a national clinical data repositoryJACC, 2001
- Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collectionJACC, 1998
- Discordance of Databases Designed for Claims Payment versus Clinical Information Systems: Implications for Outcomes ResearchAnnals of Internal Medicine, 1993